D. E. Shaw & Co., Inc. Medpace Holdings, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 372,079 shares of MEDP stock, worth $153 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares

372,079

Previous 231,560 60.68%

Holding current value

$153 Million

Previous $71 Million 111.86%

% of portfolio

0.13%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $40 Million - $58.1 Million	140,519 Added 60.68%	372,079 $150 Million
Q4 2023 Feb 14, 2024	BUY	$227.52 - $312.68 $19.8 Million - $27.3 Million	87,240 Added 60.45%	231,560 $71 Million
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $26.8 Million - $32.3 Million	-114,693 Reduced 44.28%	144,320 $34.9 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $20.3 Million - $26.1 Million	108,623 Added 72.23%	259,013 $62.2 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $1.37 Million - $1.88 Million	7,861 Added 5.52%	150,390 $28.3 Million

Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $15 Million - $22.2 Million	98,200 Added 221.53%	142,529 $30.3 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $248,752 - $312,787	-1,714 Reduced 3.72%	44,329 $6.97 Million
Q2 2022 Aug 15, 2022	BUY	$130.2 - $168.03 $2.9 Million - $3.74 Million	22,272 Added 93.69%	46,043 $6.89 Million
Q1 2022 May 16, 2022	BUY	$138.87 - $214.31 $1.71 Million - $2.65 Million	12,346 Added 108.06%	23,771 $3.89 Million
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $675,772 - $842,774	3,698 Added 47.86%	11,425 $2.49 Million
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $1.61 Million - $1.88 Million	-9,462 Reduced 55.05%	7,727 $1.46 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $2.71 Million - $3.32 Million	-17,112 Reduced 49.89%	17,189 $3.04 Million
Q1 2021 May 17, 2021	SELL	$132.02 - $168.26 $6.63 Million - $8.46 Million	-50,253 Reduced 59.43%	34,301 $5.63 Million
Q4 2020 Feb 16, 2021	SELL	$109.38 - $149.19 $20.1 Million - $27.5 Million	-184,076 Reduced 68.52%	84,554 $11.8 Million
Q3 2020 Nov 16, 2020	BUY	$92.95 - $130.61 $3.84 Million - $5.4 Million	41,310 Added 18.17%	268,630 $30 Million
Q2 2020 Aug 14, 2020	SELL	$68.08 - $95.68 $3.43 Million - $4.83 Million	-50,452 Reduced 18.16%	227,320 $21.1 Million
Q1 2020 May 15, 2020	BUY	$61.71 - $101.95 $5.62 Million - $9.29 Million	91,079 Added 48.79%	277,772 $20.4 Million
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $7.35 Million - $8.88 Million	-104,933 Reduced 35.98%	186,693 $15.7 Million
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $7.53 Million - $10.4 Million	120,688 Added 70.6%	291,626 $24.5 Million
Q2 2019 Aug 14, 2019	SELL	$53.64 - $65.42 $2.32 Million - $2.83 Million	-43,234 Reduced 20.19%	170,938 $11.2 Million
Q1 2019 May 15, 2019	SELL	$49.38 - $70.58 $4.21 Million - $6.02 Million	-85,293 Reduced 28.48%	214,172 $12.6 Million
Q4 2018 Feb 14, 2019	SELL	$46.97 - $63.98 $11.3 Million - $15.4 Million	-241,334 Reduced 44.63%	299,465 $15.9 Million
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $18.9 Million - $27.8 Million	436,834 Added 420.17%	540,799 $32.4 Million
Q2 2018 Aug 14, 2018	SELL	$34.03 - $45.46 $245,322 - $327,721	-7,209 Reduced 6.48%	103,965 $4.47 Million
Q1 2018 May 15, 2018	SELL	$32.03 - $39.05 $1.79 Million - $2.18 Million	-55,859 Reduced 33.44%	111,174 $3.88 Million
Q4 2017 Feb 14, 2018	BUY	$32.46 - $38.31 $3.29 Million - $3.88 Million	101,341 Added 154.27%	167,033 $6.06 Million
Q3 2017 Nov 14, 2017	BUY	$27.43 - $33.11 $1.8 Million - $2.18 Million	65,692	65,692 $2.1 Million

Others Institutions Holding MEDP

# of Institutions

622

Shares Held

25.1M

Call Options Held

154K

Put Options Held

117K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $12.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account